Your browser doesn't support javascript.
loading
Validation of the performance and suitability of a new class of FBS optimized for use in single-cell functional assays.
Berrong, Mark; Ferrari, Guido; Porth, Cassie; Davis, Devin; Denny, Thomas; Janetzki, Sylvia; Rountree, Wes.
Afiliación
  • Berrong M; Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.
  • Ferrari G; Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA; Duke Center for AIDS Research, Duke University Medical Center, Durham, NC 27710, USA.
  • Porth C; Duke Research and Discovery, Research Triangle Park, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University Medical Center, Durham, 27710, NC, USA.
  • Davis D; Seraworx, PO Box 202, Providence, UT 84332, USA.
  • Denny T; Duke Research and Discovery, Research Triangle Park, Durham, NC 27710, USA; Duke Human Vaccine Institute, Duke University Medical Center, Durham, 27710, NC, USA; Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA.
  • Janetzki S; ZellNet Consulting, Inc., 555 North Ave, Suite 25-S, Fort Lee, NJ 07024, USA.
  • Rountree W; Duke Human Vaccine Institute, Duke University Medical Center, Durham, NC 27710, USA; Duke Research and Discovery, Research Triangle Park, Durham, NC 27710, USA. Electronic address: wes.rountree@duke.edu.
J Immunol Methods ; 515: 113452, 2023 04.
Article en En | MEDLINE | ID: mdl-36858170

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Laboratorios Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Immunol Methods Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Laboratorios Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Immunol Methods Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos